The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 12, 2013, Pages 1825-1837

  Østergaard, Leif ^a,b   Aamand, Rasmus ^b   Karabegovic, Sanja ^a   Tietze, Anna ^a,b   Blicher, Jakob Udby ^b,c   Mikkelsen, Irene Klærke ^b   Iversen, Nina Kerting ^b   Secher, Niels ^a   Engedal, Thorbjørn Søndergaard ^a,b   Anzabi, Mariam ^b   Jimenez, Eugenio Gutierrez ^b   Cai, Changsi ^b   Koch, Klaus Ulrik ^a   Næss Schmidt, Erhard Trillingsgaard ^c   Obel, Annette ^a   Juul, Niels ^a   Rasmussen, Mads ^a   Sørensen, Jens Christian Hedemann ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c Hammel Neurorehabilitation Centre   (Denmark)

Author keywords

Capillary transit time heterogeneity; Delayed cerebral ischemia; Edema; Microcirculation; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; OXYHEMOGLOBIN;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN CAPILLARY; BRAIN ISCHEMIA; BRAIN MICROCIRCULATION; BRAIN OXYGEN CONSUMPTION; BRAIN VASOSPASM; CAPILLARY TRANSIT TIME HETEROGENEITY; COGNITIVE DEFECT; DELAYED CEREBRAL ISCHEMIA; DETERIORATION; DISEASE SEVERITY; EDEMA; HYPOXEMIA; INFLAMMATION; LEUKOCYTOSIS; MORPHOLOGY; MORTALITY; NERVE DEGENERATION; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; OXYGEN TISSUE LEVEL; PERICYTE; PRIORITY JOURNAL; REVIEW; SUBARACHNOID HEMORRHAGE; SURVIVOR; SWELLING; VASOGENIC EDEMA;

BRAIN; BRAIN ISCHEMIA; HUMANS; MICROCIRCULATION; MICROVESSELS; SUBARACHNOID HEMORRHAGE;

EID: 84889094930     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.173     Document Type: Review

References (173)

1. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet 2007; 369: 306-318. (Pubitemid 46136491)
2. Linn FH, Rinkel GJ, Algra A, van Gijn J. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke 1996; 27: 625-629. (Pubitemid 26114421)
3. Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997; 28: 660-664. (Pubitemid 27118394)
4. Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke 2010; 41: e519-e536.
5. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994; 25: 1342-1347. (Pubitemid 24198577)
6. Grote E, Hassler W. The critical first minutes after subarachnoid hemorrhage. Neurosurgery 1988; 22: 654-661.
7. Voldby B, Enevoldsen EM. Intracranial pressure changes following aneurysm rupture. Part 1: clinical and angiographic correlations. J Neurosurg 1982; 56: 186-196. (Pubitemid 12093790)
8. Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2006; 26: 1341-1353. (Pubitemid 44629883)
9. Doczi T. The pathogenetic and prognostic significance of blood-brain barrier damage at the acute stage of aneurysmal subarachnoid haemorrhage. Clinical and experimental studies. Acta Neurochir (Wien) 1985; 77: 110-132. (Pubitemid 16214427)
10. Germano A, d'Avella D, Imperatore C, Caruso G, Tomasello F. Time-course of blood-brain barrier permeability changes after experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 2000; 142: 575-580, discussion 580-1.
11. Winkler MK, Chassidim Y, Lublinsky S, Revankar GS, Major S, Kang EJ et al. Impaired neurovascular coupling to ictal epileptic activity and spreading depolarization in a patient with subarachnoid hemorrhage: possible link to blood-brain barrier dysfunction. Epilepsia 2012; 53(Suppl 6): 22-30.
12. Claassen J, Carhuapoma JR, Kreiter KT, Du EY, Connolly ES, Mayer SA. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke 2002; 33: 1225-1232. (Pubitemid 34520392)
13. Orakcioglu B, Fiebach JB, Steiner T, Kollmar R, Juttler E, Becker K et al. Evolution of early perihemorrhagic changes-ischemia vs. edema: an MRI study in rats. Exp Neurol 2005; 193: 369-376. (Pubitemid 40616186)
14. Liu Y, Soppi V, Mustonen T, Kononen M, Koivisto T, Koskela A et al. Subarachnoid hemorrhage in the subacute stage: elevated apparent diffusion coefficient in normal-appearing brain tissue after treatment. Radiology 2007; 242: 518-525. (Pubitemid 46150971)
15. Kreiter KT, Copeland D, Bernardini GL, Bates JE, Peery S, Claassen J et al. Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke 2002; 33: 200-208. (Pubitemid 34052210)
16. Hijdra A, Van Gijn J, Stefanko S, Van Dongen KJ, Vermeulen M, Van Crevel H. Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: clinicoanatomic correlations. Neurology 1986; 36: 329-333. (Pubitemid 16125148)
17. Crowley RW, Medel R, Dumont AS, Ilodigwe D, Kassell NF, Mayer SA et al. Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 2011; 42: 919-923.
18. Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991; 22: 971-982.
19. Takeuchi K, Miyata N, Renic M, Harder DR, Roman RJ. Hemoglobin, NO, and 20-HETE interactions in mediating cerebral vasoconstriction following SAH. Am J Physiol Regul Integr Comp Physiol 2006; 290: R84-R89.
20. Zimmermann M, Seifert V. Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery 1998; 43: 863-875, discussion 875-6. (Pubitemid 28436337)
21. Petzold GC, Einhaupl KM, Dirnagl U, Dreier JP. Ischemia triggered by spreading neuronal activation is induced by endothelin-1 and hemoglobin in the subarachnoid space. Ann Neurol 2003; 54: 591-598. (Pubitemid 37346065)
22. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454-456. (Pubitemid 16097810)
23. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, Bolay H, Bermpohl D, Jin H et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 2004; 113: 1447-1455. (Pubitemid 39071700)
24. Takano T, Tian GF, Peng W, Lou N, Lovatt D, Hansen AJ et al. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci 2007; 10: 754-762. (Pubitemid 46828508)
25. Pluta RM, Afshar JK, Boock RJ, Oldfield EH. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage. J Neurosurg 1998; 88: 557-561. (Pubitemid 28114731)
26. Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 2005; 105: 23-56. (Pubitemid 40044766)
27. Rey FE, Li XC, Carretero OA, Garvin JL, Pagano PJ. Perivascular superoxide anion contributes to impairment of endothelium-dependent relaxation: role of gp91(phox). Circulation 2002; 106: 2497-2502. (Pubitemid 35278808)
28. Sasaki T, Wakai S, Asano T, Watanabe T, Kirino T, Sano K. The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery. An experimental study on cerebral vasospasm. J Neurosurg 1981; 54: 357-365. (Pubitemid 11135945)
29. Pyne-Geithman GJ, Nair SG, Stamper DN, Clark JF. Role of bilirubin oxidation products in the pathophysiology of DIND following SAH. Acta Neurochir Suppl 2013; 115: 267-273.
30. Pyne-Geithman GJ, Morgan CJ, Wagner K, Dulaney EM, Carrozzella J, Kanter DS et al. Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2005; 25: 1070-1077. (Pubitemid 41061722)
31. Pluta RM, Thompson BG, Dawson TM, Snyder SH, Boock RJ, Oldfield EH. Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 1996; 84: 648-654. (Pubitemid 26104234)
32. Jung CS, Iuliano BA, Harvey-White J, Espey MG, Oldfield EH, Pluta RM. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg 2004; 101: 836-842. (Pubitemid 39430979)
33. Jung CS, Lange B, Zimmermann M, Seifert V. The CSF concentration of ADMA, but not of ET-1, is correlated with the occurrence and severity of cerebral vasospasm after subarachnoid hemorrhage. Neurosci Lett 2012; 524: 20-24.
34. Rabinstein AA, Friedman JA, Weigand SD, McClelland RL, Fulgham JR, Manno EM et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004; 35: 1862-1866. (Pubitemid 38971866)
35. Woitzik J, Dreier JP, Hecht N, Fiss I, Sandow N, Major S et al. Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2012; 32: 203-212.
36. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, doubleblind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 2011; 10: 618-625.
37. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke 2012; 43: 1463-1469.
38. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A et al. Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2). Acta Neurochir Suppl 2013; 115: 27-31.
39. Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 2009; 31: 151-158.
40. Dreier JP, Ebert N, Priller J, Megow D, Lindauer U, Klee R et al. Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg 2000; 93: 658-666. (Pubitemid 32799301)
41. Dreier JP, Woitzik J, Fabricius M, Bhatia R, Major S, Drenckhahn C et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 2006; 129: 3224-3237. (Pubitemid 44871438)
42. Koide M, Bonev AD, Nelson MT, Wellman GC. Inversion of neurovascular coupling by subarachnoid blood depends on large-conductance Ca2+-activated K+ (BK) channels. Proc Natl Acad Sci USA 2012; 109: E1387-E1395.
43. Martinaud O, Perin B, Gerardin E, Proust F, Bioux S, Gars DL et al. Anatomy of executive deficit following ruptured anterior communicating artery aneurysm. Eur J Neurol 2009; 16: 595-601.
44. Bendel P, Koivisto T, Aikia M, Niskanen E, Kononen M, Hanninen T et al. Atrophic enlargement of CSF volume after subarachnoid hemorrhage: correlation with neuropsychological outcome. AJNR Am J Neuroradiol 2010; 31: 370-376.
45. Tam AK, Ilodigwe D, Li Z, Schweizer TA, Macdonald RL. Global cerebral atrophy after subarachnoid hemorrhage: a possible marker of acute brain injury and assessment of its impact on outcome. Acta Neurochir Suppl 2013; 115: 17-21.
46. Bendel P, Koivisto T, Niskanen E, Kononen M, Aikia M, Hanninen T et al. Brain atrophy and neuropsychological outcome after treatment of ruptured anterior cerebral artery aneurysms: a voxel-based morphometric study. Neuroradiology 2009; 51: 711-722.
47. Bendel P, Koivisto T, Hanninen T, Kolehmainen A, Kononen M, Hurskainen H et al. Subarachnoid hemorrhage is followed by temporomesial volume loss: MRI volumetric study. Neurology 2006; 67: 575-582. (Pubitemid 44273601)
48. Barth M, Capelle HH, Munch E, Thome C, Fiedler F, Schmiedek P et al. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage-preliminary results from a randomized clinical series. Acta Neurochir (Wien) 2007; 149: 911-918, discussion 918. (Pubitemid 47319143)
49. Jespersen SN, Østergaard L. The roles of cerebral blood flow, capillary transit time heterogeneity and oxygen tension in brain oxygenation and metabolism. J Cereb Blood Flow Metab 2012; 32: 264-277.
50. Østergaard L, Jespersen SN, Mouridsen K, Mikkelsen IK, Jonsdottir KY, Tietze A et al. The role of the cerebral capillaries in acute ischemic stroke: the extended penumbra model. J Cereb Blood Flow Metab 2013; 33: 635-648.
51. Østergaard L, Aamand R, Gutierrez-Jimenez E, Ho Y-L, Blicher JU, Madsen SM et al. The capillary dysfunction hypothesis of Alzheimer's disease. Neurobiol Aging 2013; 34: 1018-1031.
52. Sehba FA, Friedrich V. Cerebral microvasculature is an early target of subarachnoid hemorrhage. Acta Neurochir Suppl 2013; 115: 199-205.
53. Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med 2009; 15: 1031-1037.
54. Peppiatt CM, Howarth C, Mobbs P, Attwell D. Bidirectional control of CNS capillary diameter by pericytes. Nature 2006; 443: 700-704. (Pubitemid 44564713)
55. Scholler K, Trinkl A, Klopotowski M, Thal SC, Plesnila N, Trabold R et al. Characterization of microvascular basal lamina damage and blood-brain barrier dysfunction following subarachnoid hemorrhage in rats. Brain Res 2007; 1142: 237-246. (Pubitemid 46413192)
56. Kwon I, Kim EH, del Zoppo GJ, Heo JH. Ultrastructural and temporal changes of the microvascular basement membrane and astrocyte interface following focal cerebral ischemia. J Neurosci Res 2009; 87: 668-676.
57. Yee AH, Burns JD, Wijdicks EF. Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurg Clin N Am 2010; 21: 339-352.
58. Olson JE, Banks M, Dimlich RV, Evers J. Blood-brain barrier water permeability and brain osmolyte content during edema development. Acad Emerg Med 1997; 4: 662-673. (Pubitemid 27300407)
59. LUSE SA, HARRIS B. Electron microscopy of the brain in experimental edema. J Neurosurg 1960; 17: 439-446.
60. Carare RO, Bernardes-Silva M, Newman TA, Page AM, Nicoll JA, Perry VH et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol 2008; 34: 131-144. (Pubitemid 351327967)
61. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 2012; 4: 147ra111.
62. Rennels ML, Blaumanis OR, Grady PA. Rapid solute transport throughout the brain via paravascular fluid pathways. Adv Neurol 1990; 52: 431-439.
63. Ichimura T, Fraser PA, Cserr HF. Distribution of extracellular tracers in perivascular spaces of the rat brain. Brain Res 1991; 545: 103-113.
64. Sun BL, Xia ZL, Wang JR, Yuan H, Li WX, Chen YS et al. Effects of blockade of cerebral lymphatic drainage on regional cerebral blood flow and brain edema after subarachnoid hemorrhage. Clin Hemorheol Microcirc 2006; 34: 227-232. (Pubitemid 43351034)
65. Sun BL, Xie FM, Yang MF, Cao MZ, Yuan H, Wang HT et al. Blocking cerebral lymphatic drainage deteriorates cerebral oxidative injury in rats with subarachnoid hemorrhage. Acta Neurochir Suppl 2011; 110: 49-53.
66. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature 2010; 468: 232-243.
67. Haefliger IO, Zschauer A, Anderson DR. Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway. Invest Ophthalmol Vis Sci 1994; 35: 991-997. (Pubitemid 24079830)
68. Haefliger IO, Anderson DR. Oxygen modulation of guanylate cyclase-mediated retinal pericyte relaxations with 3-morpholino-sydnonimine and atrial natriuretic peptide. Invest Ophthalmol Vis Sci 1997; 38: 1563-1568. (Pubitemid 27317852)
69. Dehouck MP, Vigne P, Torpier G, Breittmayer JP, Cecchelli R, Frelin C. Endothelin-1 as a mediator of endothelial cell-pericyte interactions in bovine brain capillaries. J Cereb Blood Flow Metab 1997; 17: 464-469. (Pubitemid 27188543)
70. Schonfelder U, Hofer A, Paul M, Funk RH. In situ observation of living pericytes in rat retinal capillaries. Microvasc Res 1998; 56: 22-29. (Pubitemid 28367119)
71. Lam HC, Lee JK, Lu CC, Chu CH, Chuang MJ, Wang MC. Role of endothelin in diabetic retinopathy. Curr Vasc Pharmacol 2003; 1: 243-250.
72. Renkin EMBW. Zweifach Award lecture. Regulation of the microcirculation. Microvasc Res 1985; 30: 251-263.
73. Provencio JJ. Inflammation in subarachnoid hemorrhage and delayed deterioration associated with vasospasm: a review. Acta Neurochir Suppl 2013; 115: 233-238.
74. Mazzoni MC, Schmid-Schonbein GW. Mechanisms and consequences of cell activation in the microcirculation. Cardiovasc Res 1996; 32: 709-719. (Pubitemid 26332310)
75. Tomita Y, Tomita M, Schiszler I, Amano T, Tanahashi N, Kobari M et al. Moment analysis of microflow histogram in focal ischemic lesion to evaluate microvascular derangement after small pial arterial occlusion in rats. J Cereb Blood Flow Metab 2002; 22: 663-669. (Pubitemid 34596458)
76. Hudetz AG, Feher G, Weigle CG, Knuese DE, Kampine JP. Video microscopy of cerebrocortical capillary flow: response to hypotension and intracranial hypertension. Am J Physiol 1995; 268: H2202-H2210.
77. Østergaard L, Sorensen AG, Chesler DA, Weisskoff RM, Koroshetz WJ, Wu O et al. Combined diffusion-weighted and perfusion-weighted flow heterogeneity magnetic resonance imaging in acute stroke. Stroke 2000; 31: 1097-1103. (Pubitemid 30253531)
78. Simonsen CZ, Rohl L, Vestergaard-Poulsen P, Gyldensted C, Andersen G, Østergaard L. Final infarct size after acute stroke: prediction with flow heterogeneity. Radiology 2002; 225: 269-275.
79. Perkio J, Soinne L, Østergaard L, Helenius J, Kangasmaki A, Martinkauppi S et al. Abnormal intravoxel cerebral blood flow heterogeneity in human ischemic stroke determined by dynamic susceptibility contrast magnetic resonance imaging. Stroke 2005; 36: 44-49. (Pubitemid 40054173)
80. Sette G, Baron JC, Mazoyer B, Levasseur M, Pappata S, Crouzel C. Local brain haemodynamics and oxygen metabolism in cerebrovascular disease. Positron emission tomography. Brain 1989; 112: Pt 4 931-951. (Pubitemid 19199477)
81. Stewart GN. Researches on the circulation time in organs and on the influences which affect it. Parts I.-III. J Physiol 1894; 15: 1-89.
82. Ndubuizu O, LaManna JC. Brain tissue oxygen concentration measurements. Antioxid Redox Signal 2007; 9: 1207-1219. (Pubitemid 47080830)
83. Moustafa RS, Baron JC. Perfusion Thresholds in Cerebral Ischemia. In: Donnan GA, Baron JC, Davis SM, Sharp FR (eds). Informa Healthcare USA, Inc.: New York, 2007, pp 31-36.
84. Pawlik G, Rackl A, Bing RJ. Quantitative capillary topography and blood flow in the cerebral cortex of cats: an in vivo microscopic study. Brain Res 1981; 208: 35-58. (Pubitemid 11130288)
85. Villringer A, Them A, Lindauer U, Einhaupl K, Dirnagl U. Capillary perfusion of the rat brain cortex. An in vivo confocal microscopy study. Circ Res 1994; 75: 55-62. (Pubitemid 24187735)
86. Kleinfeld D, Mitra PP, Helmchen F, Denk W. Fluctuations and stimulus-induced changes in blood flow observed in individual capillaries in layers 2 through 4 of rat neocortex. Proc Natl Acad Sci USA 1998; 95: 15741-15746. (Pubitemid 29018770)
87. Vogel J, Abounader R, Schrock H, Zeller K, Duelli R, Kuschinsky W. Parallel changes of blood flow and heterogeneity of capillary plasma perfusion in rat brains during hypocapnia. Am J Physiol 1996; 270: H1441-H1445.
88. Abounader R, Vogel J, Kuschinsky W. Patterns of capillary plasma perfusion in brains in conscious rats during normocapnia and hypercapnia. Circ Res 1995; 76: 120-126.
89. Krolo I, Hudetz AG. Hypoxemia alters erythrocyte perfusion pattern in the cerebral capillary network. Microvasc Res 2000; 59: 72-79. (Pubitemid 30073139)
90. Nelson RJ, Perry S, Hames TK, Pickard JD. Transcranial Doppler ultrasound studies of cerebral autoregulation and subarachnoid hemorrhage in the rabbit. J Neurosurg 1990; 73: 601-610. (Pubitemid 20319481)
91. Grosset DG, Straiton J, McDonald I, Cockburn M, Bullock R. Use of transcranial Doppler sonography to predict development of a delayed ischemic deficit after subarachnoid hemorrhage. J Neurosurg 1993; 78: 183-187. (Pubitemid 23039116)
92. Aaslid R, Huber P, Nornes H. Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg 1984; 60: 37-41. (Pubitemid 14181553)
93. Oertel MF, Scharbrodt W, Wachter D, Stein M, Schmidinger A, Boker DK. Arteriovenous differences of oxygen and transcranial Doppler sonography in the management of aneurysmatic subarachnoid hemorrhage. J Clin Neurosci 2008; 15: 630-636.
94. Voldby B, Enevoldsen EM, Jensen FT. Regional CBF, intraventricular pressure, and cerebral metabolism in patients with ruptured intracranial aneurysms. J Neurosurg 1985; 62: 48-58. (Pubitemid 15199403)
95. Cho HG, Shin HK, Shin YW, Lee JH, Hong KW. Role of nitric oxide in the CBF autoregulation during acute stage after subarachnoid haemorrhage in rat pial artery. Fundam Clin Pharmacol 2003; 17: 563-573. (Pubitemid 37215080)
96. Lassen NA. The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain. Lancet 1966; 2: 1113-1115.
97. Voldby B, Enevoldsen EM, Jensen FT. Cerebrovascular reactivity in patients with ruptured intracranial aneurysms. J Neurosurg 1985; 62: 59-67. (Pubitemid 15199404)
98. Wang Z, Meng CJ, Shen XM, Shu Z, Ma C, Zhu GQ et al. Potential contribution of hypoxia-inducible factor-1alpha, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhage. J Mol Neurosci 2012; 48: 273-280.
99. Yuan G, Khan SA, Luo W, Nanduri J, Semenza GL, Prabhakar NR. Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. J Cell Physiol 2011; 226: 2925-2933.
100. Shin HK, Lee JH, Kim KY, Kim CD, Lee WS, Rhim BY et al. Impairment of autoregulatory vasodilation by NAD(P)H oxidase-dependent superoxide generation during acute stage of subarachnoid hemorrhage in rat pial artery. J Cereb Blood Flow Metab 2002; 22: 869-877. (Pubitemid 34747604)
101. Dawson VL, Dawson TM. Nitric oxide neurotoxicity. J Chem Neuroanat 1996; 10: 179-190. (Pubitemid 26197684)
102. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315-424. (Pubitemid 46217686)
103. Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction. Cell Metab 2008; 7: 476-484. (Pubitemid 351729202)
104. Sabri M, Ai J, Lakovic K, Macdonald RL. Mechanisms of microthrombosis and microcirculatory constriction after experimental subarachnoid hemorrhage. Acta Neurochir Suppl 2013; 115: 185-192.
105. Friedrich B, Muller F, Feiler S, Scholler K, Plesnila N. Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in vivo microscopy study. J Cereb Blood Flow Metab 2012; 32: 447-455.
106. Powers WJ, Grubb Jr RL, Baker RP, Mintun MA, Raichle ME. Regional cerebral blood flow and metabolism in reversible ischemia due to vasospasm. Determination by positron emission tomography. J Neurosurg 1985; 62: 539-546. (Pubitemid 15079419)
107. Kawamura S, Sayama I, Yasui N, Uemura K. Sequential changes in cerebral blood flow and metabolism in patients with subarachnoid haemorrhage. Acta Neurochir (Wien) 1992; 114: 12-15.
108. Minhas PS, Menon DK, Smielewski P, Czosnyka M, Kirkpatrick PJ, Clark JC et al. Positron emission tomographic cerebral perfusion disturbances and transcranial Doppler findings among patients with neurological deterioration after subarachnoid hemorrhage. Neurosurgery 2003; 52: 1017-1022, discussion 1022-4.
109. Al-Rawi PG, Zygun D, Tseng MY, Hutchinson PJ, Matta BF, Kirkpatrick PJ. Cerebral blood flow augmentation in patients with severe subarachnoid haemorrhage. Acta Neurochir Suppl 2005; 95: 123-127.
110. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011; 364: 656-665.
111. Reinprecht A, Czech T, Asenbaum S, Podreka I, Schmidbauer M. Low cerebrovascular reserve capacity in long-term follow-up after subarachnoid hemorrhage. Surg Neurol 2005; 64: 116-120, discussion 121. (Pubitemid 41044130)
112. Szabo S, Sheth RN, Novak L, Rozsa L, Ficzere A. Cerebrovascular reserve capacity many years after vasospasm due to aneurysmal subarachnoid hemorrhage. A transcranial Doppler study with acetazolamide test. Stroke 1997; 28: 2479-2482. (Pubitemid 28007654)
113. Jeon H, Ai J, Sabri M, Tariq A, Shang X, Chen G et al. Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage. BMC Neurosci 2009; 10: 103-2202-10-103.
114. Neil-Dwyer G, Cruickshank J. The blood leucocyte count and its prognostic significance in subarachnoid haemorrhage. Brain 1974; 97: 79-86.
115. Parkinson D, Stephensen S. Leukocytosis and subarachnoid hemorrhage. Surg Neurol 1984; 21: 132-134. (Pubitemid 14183422)
116. McGirt MJ, Mavropoulos JC, McGirt LY, Alexander MJ, Friedman AH, Laskowitz DT et al. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003; 98: 1222-1226. (Pubitemid 36617925)
117. Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke 2009; 40: 1963-1968.
118. Mouridsen K, Friston K, Hjort N, Gyldensted L, Østergaard L, Kiebel S. Bayesian estimation of cerebral perfusion using a physiological model of microvasculature. Neuroimage 2006; 33: 570-579. (Pubitemid 44485544)
119. Mouridsen K, Østergaard L, Christensen S, Jespersen SN. Reliable estimation of capillary transit time distributions at voxel-level using DSC-MRI. Proc Int Soc Magn Reson Med 19th Annual Meeting and Exhibition 2011 3915.
120. Kate M, Hansen MB, Mouridsen K, Østergaard L, Choi V, Gould B et al. Blood pressure reduction does not reduce perihematoma oxygenation. J Cereb Blood Flow Metab; advance online publication, 18 September 2013; doi:10.1038/jcbfm.2013.164.
121. Ayer RE, Zhang JH. Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir Suppl 2008; 104: 33-41.
122. Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol 2003; 2: 614-621.
123. Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care 2010; 14: R23.
124. Connolly Jr ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012; 43: 1711-1737.
125. Borges N, Shi F, Azevedo I, Audus KL. Changes in brain microvessel endothelial cell monolayer permeability induced by adrenergic drugs. Eur J Pharmacol 1994; 269: 243-248.
126. Stocchetti N. Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Triggers for aggressive interventions in subarachnoid hemorrhage. Neurocrit Care 2011; 15: 324-328.
127. Muench E, Horn P, Bauhuf C, Roth H, Philipps M, Hermann P et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med 2007; 35: 1844-1851quiz 1852. (Pubitemid 47220357)
128. Grande PO. The "Lund Concept" for the treatment of severe head trauma-physiological principles and clinical application. Intensive Care Med 2006; 32: 1475-1484.
129. Dizdarevic K, Hamdan A, Omerhodzic I, Kominlija-Smajic E. Modified Lund concept versus cerebral perfusion pressure-targeted therapy: a randomised controlled study in patients with secondary brain ischaemia. Clin Neurol Neurosurg 2012; 114: 142-148.
130. Kamel H, Navi BB, Nakagawa K, Hemphill 3rd JC, Ko NU. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med 2011; 39: 554-559.
131. Mortazavi MM, Romeo AK, Deep A, Griessenauer CJ, Shoja MM, Tubbs RS et al. Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis. J Neurosurg 2012; 116: 210-221.
132. Torre-Healy A, Marko NF, Weil RJ. Hyperosmolar therapy for intracranial hypertension. Neurocrit Care 2012; 17: 117-130.
133. Bermueller C, Thal SC, Plesnila N, Schmid-Elsaesser R, Kreimeier U, Zausinger S. Hypertonic fluid resuscitation from subarachnoid hemorrhage in rats: a comparison between small volume resuscitation and mannitol. J Neurol Sci 2006; 241: 73-82. (Pubitemid 43112519)
134. Pascual JL, Khwaja KA, Chaudhury P, Christou NV. Hypertonic saline and the microcirculation. J Trauma 2003; 54: S133-S140. (Pubitemid 36758863)
135. Al-Rawi PG, Tseng MY, Richards HK, Nortje J, Timofeev I, Matta BF et al. Hypertonic saline in patients with poor-grade subarachnoid hemorrhage improves cerebral blood flow, brain tissue oxygen, and pH. Stroke 2010; 41: 122-128.
136. Nakagawa I, Hironaka Y, Nishimura F, Takeshima Y, Matsuda R, Yamada S et al. Early inhibition of natriuresis suppresses symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis 2013; 35: 131-137.
137. Kasprowicz M, Czosnyka M, Soehle M, Smielewski P, Kirkpatrick PJ, Pickard JD et al. Vasospasm shortens cerebral arterial time constant. Neurocrit Care 2012; 16: 213-218.
138. Tseng MY, Al-Rawi PG, Pickard JD, Rasulo FA, Kirkpatrick PJ. Effect of hypertonic saline on cerebral blood flow in poor-grade patients with subarachnoid hemorrhage. Stroke 2003; 34: 1389-1396. (Pubitemid 36693503)
139. Tseng MY, Al-Rawi PG, Czosnyka M, Hutchinson PJ, Richards H, Pickard JD et al. Enhancement of cerebral blood flow using systemic hypertonic saline therapy improves outcome in patients with poor-grade spontaneous subarachnoid hemorrhage. J Neurosurg 2007; 107: 274-282. (Pubitemid 47219369)
140. Hauer EM, Stark D, Staykov D, Steigleder T, Schwab S, Bardutzky J. Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease. Crit Care Med 2011; 39: 1766-1772.
141. Froelich M, Ni Q, Wess C, Ougorets I, Hartl R. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med 2009; 37: 1433-1441.
142. Bentsen G, Breivik H, Lundar T, Stubhaug A. Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage. Crit Care Med 2006; 34: 2912-2917. (Pubitemid 44808731)
143. van Faassen EE, Bahrami S, Feelisch M, Hogg N, Kelm M, Kim-Shapiro DB et al. Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev 2009; 29: 683-741.
144. Montenegro MF, Amaral JH, Pinheiro LC, Sakamoto EK, Ferreira GC, Reis RI et al. Sodium nitrite downregulates vascular NADPH oxidase and exerts antihypertensive effects in hypertension. Free Radic Biol Med 2011; 51: 144-152.
145. Shiva S. Mitochondria as metabolizers and targets of nitrite. Nitric Oxide 2010; 22: 64-74.
146. Shiva S. Nitrite: a physiological store of nitric oxide and modulator of mitochondrial function. Redox Biol 2013; 1: 40-44.
147. Larsen FJ, Schiffer TA, Borniquel S, Sahlin K, Ekblom B, Lundberg JO et al. Dietary inorganic nitrate improves mitochondrial efficiency in humans. Cell Metab 2011; 13: 149-159.
148. Park JW, Piknova B, Huang PL, Noguchi CT, Schechter AN. Effect of blood nitrite and nitrate levels on murine platelet function. PLoS One 2013; 8: e55699.
149. Pluta RM, Dejam A, Grimes G, Gladwin MT, Oldfield EH. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid
150. Fathi AR, Pluta RM, Bakhtian KD, Qi M, Lonser RR. Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates. J Neurosurg 2011; 115: 1213-1220.
151. Jung KH, Chu K, Ko SY, Lee ST, Sinn DI, Park DK et al. Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia-reperfusion injury. Stroke 2006; 37: 2744-2750. (Pubitemid 44922536)
152. Pluta RM. Prolonged intravenous infusion of sodium nitrite delivers nitric oxide (NO) in humans. Acta Neurochir Suppl 2013; 115: 49-51.
153. Oldfield EH, Loomba JJ, Monteith SJ, Crowley RW, Medel R, Gress DR et al. Safety and pharmacokinetics of sodium nitrite in patients with subarachnoid hemorrhage: a phase IIA study. J Neurosurg 2013; 119: 634-641.
154. Yarnitsky D, Lorian A, Shalev A, Zhang ZD, Takahashi M, Agbaje-Williams M et al. Reversal of cerebral vasospasm by sphenopalatine ganglion stimulation in a dog model of subarachnoid hemorrhage. Surg Neurol 2005; 64: 5-11, discussion 11. (Pubitemid 40916952)
155. Takahashi M, Zhang ZD, Macdonald RL. Sphenopalatine ganglion stimulation for vasospasm after experimental subarachnoid hemorrhage. J Neurosurg 2011; 114: 1104-1109.
156. Nozaki K, Moskowitz MA, Maynard KI, Koketsu N, Dawson TM, Bredt DS et al. Possible origins and distribution of immunoreactive nitric oxide synthasecontaining nerve fibers in cerebral arteries. J Cereb Blood Flow Metab 1993; 13: 70-79. (Pubitemid 23016603)
157. Toda N, Ayajiki K, Yoshida K, Kimura H, Okamura T. Impairment by damage of the pterygopalatine ganglion of nitroxidergic vasodilator nerve function in canine cerebral and retinal arteries. Circ Res 1993; 72: 206-213.
158. Edvinsson L, Hamel E. Perivascular nerves in brain vessels. In: Edvinsson L, Krause DN (eds). Cerebral Blood Flow and Metabolism. Lippincott Williams & Wilkins: Philadelphia, 2002, pp 43-67.
159. Iadecola C, Beitz AJ, Renno W, Xu X, Mayer B, Zhang F. Nitric oxide synthasecontaining neural processes on large cerebral arteries and cerebral microvessels. Brain Res 1993; 606: 148-155. (Pubitemid 23084906)
160. Ishikawa M, Kusaka G, Yamaguchi N, Sekizuka E, Nakadate H, Minamitani H et al. Platelet and leukocyte adhesion in the microvasculature at the cerebral surface immediately after subarachnoid hemorrhage. Neurosurgery 2009; 64: 546-553, discussion 553-4.
161. Gallia GL, Tamargo RJ. Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurol Res 2006; 28: 750-758. (Pubitemid 44656101)
162. Katayama Y, Haraoka J, Hirabayashi H, Kawamata T, Kawamoto K, Kitahara T et al. A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007; 38: 2373-2375. (Pubitemid 47457586)
163. Feigin VL, Anderson N, Rinkel GJ, Algra A, van Gijn J, Bennett DA. Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev 2005 CD004583.
164. McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002; 33: 2950-2956. (Pubitemid 35462871)
165. Parra A, Kreiter KT, Williams S, Sciacca R, Mack WJ, Naidech AM et al. Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery 2005; 56: 476-484, discussion 476-84.
166. Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005; 36: 1627-1632. (Pubitemid 41098752)
167. Kramer AH. Statins in the management of aneurysmal subarachnoid hemorrhage: an overview of animal research, observational studies, randomized controlled trials and meta-analyses. Acta Neurochir Suppl 2011; 110: 193-201.
168. Tseng MY. Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Summary of evidence on immediate statins therapy following aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011; 15: 298-301.
169. Laufs U, Wassmann S, Hilgers S, Ribaudo N, Bohm M, Nickenig G. Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am J Cardiol 2001; 88: 1306-1307. (Pubitemid 33132103)
170. Zschauer AO, Davis EB, Anderson DR. Glaucoma, capillaries and pericytes.4 Beta-adrenergic activation of cultured retinal pericytes. Ophthalmologica 1996; 210: 276-279. (Pubitemid 26276079)
171. Kawamura H, Kobayashi M, Li Q, Yamanishi S, Katsumura K, Minami M et al. Effects of angiotensin II on the pericyte-containing microvasculature of the rat retina. J Physiol 2004; 561: 671-683. (Pubitemid 40074927)
172. Matsugi T, Chen Q, Anderson DR. Contractile responses of cultured bovine retinal pericytes to angiotensin II. Arch Ophthalmol 1997; 115: 1281-1285. (Pubitemid 27435566)
173. Rasmussen G, Bergholdt B, Dahl B, Sunde N, Cold G, Voldby B. Effect of nimodipine on cerebral blood flow and cerebrovascular reactivity after subarachnoid haemorrhage. Acta Neurol Scand 1999; 99: 182-186. (Pubitemid 29111413)